Hexakis(2,2-dimethylpropan-1-olate);tris(2-(3-oxido-2-pyridinyl)pyridin-3-olate);tris(titanium(4+))
C60H84N6O12Ti3 — CID 139041560
Data last refreshed: (MolForge compound catalog, from PubChem)
About Hexakis(2,2-dimethylpropan-1-olate);tris(2-(3-oxido-2-pyridinyl)pyridin-3-olate);tris(titanium(4+))
Hexakis(2,2-dimethylpropan-1-olate);tris(2-(3-oxido-2-pyridinyl)pyridin-3-olate);tris(titanium(4+)) (PubChem CID 139041560) has the molecular formula C60H84N6O12Ti3 and a molecular weight of 1224.96 g/mol. Its IUPAC name is hexakis(2,2-dimethylpropan-1-olate);tris(2-(3-oxido-2-pyridinyl)pyridin-3-olate);tris(titanium(4+)).
Molecular Properties
| Compound Name | Hexakis(2,2-dimethylpropan-1-olate);tris(2-(3-oxido-2-pyridinyl)pyridin-3-olate);tris(titanium(4+)) |
|---|---|
| PubChem CID | 139041560 |
| Molecular Formula | C60H84N6O12Ti3 |
| Molecular Weight | 1224.96 g/mol |
| Exact Mass | 1224.46 |
| IUPAC Name | hexakis(2,2-dimethylpropan-1-olate);tris(2-(3-oxido-2-pyridinyl)pyridin-3-olate);tris(titanium(4+)) |
| SMILES | CC(C)(C)C[O-].CC(C)(C)C[O-].CC(C)(C)C[O-].CC(C)(C)C[O-].CC(C)(C)C[O-].CC(C)(C)C[O-].[O-]c1cccnc1-c1ncccc1[O-].[O-]c1cccnc1-c1ncccc1[O-].[O-]c1cccnc1-c1ncccc1[O-].[Ti+4].[Ti+4].[Ti+4] |
| InChI | InChI=1S/3C10H8N2O2.6C5H11O.3Ti/c3*13-7-3-1-5-11-9(7)10-8(14)4-2-6-12-10;6*1-5(2,3)4-6;;;/h3*1-6,13-14H;6*4H2,1-3H3;;;/q;;;6*-1;3*+4/p-6 |
| InChIKey | NZDGUOIRELCRGQ-UHFFFAOYSA-H |
| XLogP | 3.22 |
| TPSA | 354.06 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 18 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 81 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1224.96 |
| LogP ≤ 5 | 3.22 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 18 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139041560 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.